In this article
announced Friday it now offers Novo Nordisk
’s Wegovy weight loss pill through its digital pharmacy.
Novo Nordisk began rolling out an oral version of its injectable obesity drug Wegovy in the U.S. on Monday, offering a starting dose for cash-paying patients at $149 per month. Patients with insurance coverage can get the pill for as low as $25 a month.
The daily pill enters the market with some of the lowest cash prices in the booming obesity and diabetes drug space, which costly weekly injections from Novo Nordisk and Eli Lilly have long dominated. Its availability on Amazon underscores Novo Nordisk’s strategy to expand beyond traditional channels and reach new patients.
